Cite

HARVARD Citation

    Al‐Ezzi, E. et al. (2021). Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor. Oncologist. pp. e710-e714. [Online]. 
  
Back to record